journal contribution
posted on 2023-05-23, 14:00 authored by Temara Cross, Anthony George, Kristopher Attwood, Yali Zhang, Tracey L. O'Connor, Nancy Barone, Karen Hulme, Christine B. Ambrosone, Song Yao, Chi-Chen Hong Supplementary Table from Associations between Serum 25-Hydroxyvitamin D Levels and Health-Related Quality-of-Life Measures in Patients with Breast Cancer: A Longitudinal Study
Funding
Susan G. Komen (SGK)
Breast Cancer Research Foundation (BCRF)
U.S. Department of Defense (DOD)
New York State Department of Health - Wadsworth Center (NYSDOH)
Roswell Park Alliance Foundation, Roswell Park Cancer Institute
National Cancer Institute (NCI)
United States Department of Health and Human Services
Find out more...History
ARTICLE ABSTRACT
Recent evidence suggests that vitamin D might lower breast cancer mortality. There is also growing interest in vitamin D's potential association with health-related quality-of-life (HRQoL). Associations between circulating 25-hydroxyvitamin D (25OHD) concentrations and HRQoL were examined prospectively among breast cancer survivors at the time of diagnosis and 1 year later.
504 women with incident early-stage breast cancer at Roswell Park Comprehensive Cancer Center were included, and 372 patients provided assessments 1 year later. At each timepoint, participants provided blood samples and completed the SF-36 Health Survey, and surveys on perceived stress, depression, and fatigue. Season-adjusted serum 25OHD concentrations were analyzed in relation to HRQoL measures using multivariable logistic regression models.
Approximately 32% of participants had deficient vitamin D levels at diagnosis, which decreased to 25% at 1 year. Concurrently, although SF-36 physical health summary scores were lower at 1 year, mental health summary scores improved, and levels of depression and perceived stress were lower. In comparison with women with sufficient 25OHD levels (>30 ng/mL) at diagnosis, those who were deficient (<20 ng/mL) had significantly worse HRQoL at diagnosis and 1 year later. Vitamin D deficiency 1 year post-diagnosis was also associated with worse HRQoL, particularly among breast cancer survivors who took vitamin D supplements.
Breast cancer survivors with vitamin D deficiency were more likely to report lower HRQoL than those with sufficient levels at the time of diagnosis and 1 year post-diagnosis.
Our results indicate a potential benefit of vitamin D supplementation for improving breast cancer survivorship.
